Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 30, 2026

Conditions
Chronic Pulmonary Aspergillosis
Interventions
DRUG

Rezafungin Acetate

IV with a 400 mg loading dose on Day 1 of Week 1, followed by 200 mg once weekly, for a total of 26 doses (6 months).

Trial Locations (37)

Unknown

NOT_YET_RECRUITING

Kepler University Hospital, Linz

NOT_YET_RECRUITING

Brussels University Hospital, Brussels

NOT_YET_RECRUITING

UZ Gent, Ghent

NOT_YET_RECRUITING

University Hospital Leuven, Leuven

NOT_YET_RECRUITING

CHU UCL Namur, Yvoir

NOT_YET_RECRUITING

CHU Amiens Picardie, Amiens

NOT_YET_RECRUITING

Institut Coeur Poumon CHU, Lille

NOT_YET_RECRUITING

CHU Arnaud de Villeneuve, Montpellier

NOT_YET_RECRUITING

CHU Bordeaux, Pessac

NOT_YET_RECRUITING

CHU de Rouen, Rouen

NOT_YET_RECRUITING

Evangelische Lungenklinik Berlin, Berlin

NOT_YET_RECRUITING

University of Cologne, Cologne

NOT_YET_RECRUITING

Asklepios Lungenfachklinik Gauting, Gauting

NOT_YET_RECRUITING

Országos Korányi Pulmonológiai Intézet, Budapest

NOT_YET_RECRUITING

University of Genova, San Martino Hospital, Genova

NOT_YET_RECRUITING

University of Pisa, Pisa

NOT_YET_RECRUITING

INMI Lazzaro Spallanzaniconsu, Roma

NOT_YET_RECRUITING

Humanitas Research Hospital, Rozzano

NOT_YET_RECRUITING

Radboud Universitair Medisch Centrum Stichting, Nijmegen

RECRUITING

Chonnam National University Hospital, Gwangju

RECRUITING

Seoul National University Bundang Hospital, Seoul

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

NOT_YET_RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

NOT_YET_RECRUITING

Hospital Universitari de Bellvitge, Barcelona

NOT_YET_RECRUITING

Vall d'Hebron Barcelona Hospital Campus, Barcelona

NOT_YET_RECRUITING

Ramón y Cajal Hospital, Madrid

NOT_YET_RECRUITING

Hospital Sant Joan de Deu de Martorell, Martorell

NOT_YET_RECRUITING

Hospital La Fe, Valencia

NOT_YET_RECRUITING

Royal Papworth Hospital, Cambridge

NOT_YET_RECRUITING

University Hospitals of Derby and Burton, Derby

RECRUITING

Western General Hospital, Edinburgh

RECRUITING

Leeds Teaching Hospital, Leeds

RECRUITING

Imperial College Hospital, London

NOT_YET_RECRUITING

Royal Brompton Hospital, Guy's and St. Thomas' Hospital, London

RECRUITING

University College London (UCL) Hospitals, London

RECRUITING

Manchester University Hospital, Manchester

All Listed Sponsors
lead

Mundipharma Research Limited

INDUSTRY

NCT06794554 - Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options | Biotech Hunter | Biotech Hunter